Business Context and Reporting Period
Company: Netcapital Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 2, 2026
Event: Entry into a Material Definitive Agreement (Equity Purchase Agreement) with Hudson Global Ventures, LLC.
Key Financial Metrics and Transaction Terms
This filing details a financing arrangement rather than reporting period-end financial results (revenue, profit, or cash flow). Key transaction metrics include:
- Total Commitment: Up to $15,000,000 in aggregate purchase price for Common Stock.
- Issuance Cap (Exchange Cap): Limited to 1,568,795 shares of Common Stock unless shareholder approval is obtained.
- Put Notice Terms:
- Minimum amount: $25,000.
- Maximum amount: Lesser of $2,000,000 or 200% of the average daily trading value.
- Purchase Price: Lesser of 92% of the average of the three lowest traded prices over the preceding 10 trading days or 92% of the lowest traded price during the valuation period.
- Warrant Issuance:
- Shares: Up to 1,000,000 shares of Common Stock.
- Exercise Price: $0.50 per share.
- Term: Exercisable from June 29, 2026, through June 29, 2029.
- Beneficial Ownership Limitation: 4.99% (adjustable up to 9.99% with notice).
Material Changes and Conditions
The filing discloses the closing of a new equity financing facility. Material conditions and restrictions include:
- Registration Rights: The Company must file a registration statement within 90 days covering the resale of the Warrant shares and future shares issued under the agreement.
- Market Conditions: The Investor's obligation to purchase is subject to the Common Stock not being deemed a "penny stock," continued listing on Nasdaq, and no "DTC chill."
- Warrant Restrictions: The Warrant becomes non-exercisable if the Common Stock is deemed a "penny stock" under SEC Rule 240.3a51-1.
- Concurrent Transactions: This closing occurred concurrently with a financing transaction previously disclosed in an 8-K filed on July 8, 2026 (note: the source text lists this future date, which may indicate a typo in the original filing or a specific reporting sequence).
Guidance, Outlook, and Risks
Management Commentary: The filing does not contain forward-looking guidance, earnings outlook, or management commentary regarding operational performance. It is strictly a disclosure of the agreement terms.
Risks and Contingencies:
- Dilution Risk: Issuance of up to 1,568,795 shares plus 1,000,000 warrant shares could dilute existing shareholders.
- Pricing Risk: The purchase price formula (92% of low prices) may result in significant dilution if the stock price declines.
- Regulatory Risk: Failure to maintain Nasdaq listing or compliance with SEC reporting requirements could terminate the Investor's obligation to purchase.
- Liquidity Risk: The Warrant may only be exercised on a cashless basis if no effective registration statement is available.
Investor Verification Checklist
- Verify the current trading price of NCPL to assess the potential dilution impact of the 92% pricing formula.
- Confirm the status of the "concurrent financing transaction" referenced as filed on July 8, 2026, to understand the total capital raised.
- Review the full text of the Equity Purchase Agreement (Exhibit 10.1) for specific conditions precedent to the Investor's obligation.
- Monitor the filing of the required registration statement within the 90-day window to ensure the Warrant remains exercisable.
- Check if shareholder approval for the Exchange Cap (1,568,795 shares) has been or will be sought.